Islet amyloid and type 2 diabetes mellitus.
Höppener
J W
JW
Department of Internal Medicine, University Medical Center, Utrecht, The Netherlands. j.w.m.hoeppener@lab.azu.nl
Ahrén
B
B
Lips
C J
CJ
D000682:Amyloid / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D000686:Amyloidosis / Q000150:complications / Q000517:prevention & control; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006801:Humans; D058228:Islet Amyloid Polypeptide; D007515:Islets of Langerhans / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D010182:Pancreatic Diseases / Q000150:complications / Q000517:prevention & control
D000682:Amyloid; D058228:Islet Amyloid Polypeptide